Supplements: A Fix for Weight Drug Woes?

GLP-1 drugs, popular for treating obesity and type 2 diabetes, have led millions of Americans to explore dietary supplements to manage common side effects such as gastrointestinal distress and fatigue. The U.S. supplement market experienced significant growth, surpassing $74 billion in 2025. Users often turn to supplements like fiber, collagen, and electrolytes, incurring costs of up to $300 monthly, which are not covered by insurance.

Concerns are mounting over the loosely regulated nature of the supplement industry. Unlike pharmaceuticals, vitamins and supplements do not require pre-approval from the U.S. Food and Drug Administration (FDA), making scientific credibility difficult to verify. Social media influencers play a large role in promoting these products, leading medical professionals to call for increased regulation of online marketing.

Retailers are expanding their supplement offerings to meet demand, with brands like Target and The Vitamin Shoppe reporting increased sales in popular items among GLP-1 users. Acquisitions in the supplement sector are also increasing in value. Meanwhile, the U.S. Health and Human Services is proposing stricter regulations, aiming to enhance oversight of dietary ingredients and potentially eliminate pathways that allow companies to declare ingredients as safe without FDA notification.

While some industry players support enhanced regulation to combat issues like ingredient spiking, others express concerns about potential backlogs and the FDA's capacity to review new ingredients at the pace of innovation. The agency is reportedly exploring ways to modernize its regulatory approach to balance consumer safety with market demands.